EUVIMEDEUVIMED entdecken
Crossref

Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt

Elena Motto, Chiara Becchetti, Giovanni Perricone, Raffaella Viganò, Fosca Anna Luisa Quarti Trevano, Francesca Bolis, Vangeli Marcello, Stella De Nicola, Francesco Morelli, Carmine Andriulo, Alice Phillips, Carmela Furci und 6 weitere

Liver International · 2025

DOI: 10.1111/liv.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Elena Motto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. Hauptthemen laut MEDLINE: Portasystemic Shunt, Transjugular Intrahepatic, Liver Cirrhosis, Cardiomyopathies. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Cirrhotic cardiomyopathy (CCM), particularly diastolic dysfunction (DD), often remains silent until stress occurs. Transjugular intrahepatic portosystemic shunt (TIPS) may unmask DD due to hemodynamic shifts. However, data supporting the utility in selecting patients before TIPS of new CCM criteria and DD remains inconclusive. We aim to assess the impact of TIPS on post‐procedural cardiac and liver outcomes, using different CCM criteria.

Methods

We retrospectively studied cirrhotic patients who underwent TIPS between January 2014 and December 2022. Demographic, clinical, echocardiographic and hemodynamic data were collected, along with 6‐month outcomes: major cardiovascular events (MACE), liver transplant (LT) and death. DD was assessed through 2005 and 2019 criteria.

Results

We included 184 patients (71% male, mean age 56 [IQR 53–54]). DD prevalence was 90% with 2005 and 25% with 2019 criteria. MACE occurred in 8% and mostly early post‐TIPS. Patients with DD (2019 criteria) were older (62 vs. 56 years, p = 0.001) and had higher NT‐proBNP (165 vs. 87 pg/mL, p = 0.05), but no increased rate of MACE (11% vs. 3%; p = 0.29) or composite LT/death (14% vs. 18%; p = 0.55) were observed. No independent MACE predictors emerged. Conversely, liver disease severity, assessed by MELD (HR 1.36, 95% CI 1.18–1.56, p < 0.001) and pre‐TIPS portal pressure gradient (HR 1.10, 95% CI 1.01–1.21, p = 0.038), was independently associated with LT‐free survival.

Conclusions

New DD criteria have limited predictive value for adverse outcomes post‐TIPS. In contrast, liver disease severity emerged as the predominant predictor of outcome, underscoring its importance in patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Portasystemic Shunt, Transjugular IntrahepaticLiver CirrhosisCardiomyopathiesHumansMaleFemaleMiddle AgedRetrospective StudiesNatriuretic Peptide, BrainLiver TransplantationEchocardiographyDiastolePeptide Fragments

Stichwörter der Autor:innen

cirrhotic cardiomyopathydiastolic dysfunctionechocardiographyliver hemodynamicliver transplantationportal hypertension

Substanzen

Natriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Peptide Fragments

Autor:innen und Institutionen

  • Hepatology and Gastroenterology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Clinica Medica, Department of Medicine, University Milano-Bicocca, Monza, Italy.
  • Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Interventional Radiology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cardiology Division, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • University of Milano-Bicocca, Monza, Italy.

ORCID-Profile: Luca Saverio Belli

Zitieren

APA

Motto, E., Becchetti, C., Perricone, G., Viganò, R., Trevano, F. A. L. Q., Bolis, F., Marcello, V., De Nicola, S., Morelli, F., Andriulo, C., Phillips, A., Furci, C., Musca, F., De Marco, P., Conti, S., Solcia, M., Belli, L. S., & Airoldi, A. (2025). Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt. Liver International. https://doi.org/10.1111/liv.70448

Vancouver

Motto E, Becchetti C, Perricone G, Viganò R, Trevano FALQ, Bolis F, et al. Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt. Liver International. 2025. doi:10.1111/liv.70448

BibTeX
@article{Motto2025,
  author = {Motto, Elena and Becchetti, Chiara and Perricone, Giovanni and Viganò, Raffaella and Trevano, Fosca Anna Luisa Quarti and Bolis, Francesca and Marcello, Vangeli and De Nicola, Stella and Morelli, Francesco and Andriulo, Carmine and Phillips, Alice and Furci, Carmela and Musca, Francesco and De Marco, Paride and Conti, Sara and Solcia, Marco and Belli, Luca Saverio and Airoldi, Aldo},
  title = {Relevance of the Diagnostic Criteria for Diastolic Dysfunction in Patients With Transjugular Intrahepatic Portosystemic Shunt},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70448}
}
Kostenlos starten →